» Articles » PMID: 38994059

Transcriptomic and Proteomic Investigations Identify PI3K-akt Pathway Targets for Hyperthyroidism Management in Rats Via Polar Iridoids from

Overview
Journal Heliyon
Specialty Social Sciences
Date 2024 Jul 12
PMID 38994059
Authors
Affiliations
Soon will be listed here.
Abstract

High-polarity iridoids from () offer a range of benefits, including anti-inflammatory, antioxidant, antitumour, antibacterial, antiviral, and antiallergic effects. Although previous studies have indicated the potential of for hyperthyroidism prevention and treatment, the specific active compounds involved and their mechanisms of action are not fully understood. This study explored the effects of high-polarity iridoid glycosides from on hyperthyroidism induced in rats by levothyroxine sodium. The experimental design included a control group, a hyperthyroidism model group, and a group treated with iridoid glycosides. Serum triiodothyronine (T3) and thyroxine (T4) levels were quantified using an enzyme-linked immunosorbent assay (ELISA). Transcriptomic and proteomic analyses were applied to liver samples to identify differentially expressed genes and proteins. These analyses were complemented by trend analysis and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis. The effectiveness of key factors was further examined through molecular biology techniques. ELISA results indicated a notable increase in T3 and T4 in the hyperthyroid rats, which was significantly mitigated by treatment with iridoid glycosides. Transcriptomic analysis revealed 6 upregulated and 6 downregulated genes in the model group, showing marked improvement following treatment. Proteomic analysis revealed changes in 30 upregulated and 50 downregulated proteins, with improvements observed upon treatment. The PI3K-Akt signalling pathway was investigated through KEGG enrichment analysis. Molecular biology methods verified the upregulation of Spp1, Thbs1, PI3K, and Akt in the model group, which was reversed in the treatment group. This study revealed that highly polar iridoids from can modulate the Spp1 gene and Thbs1 protein via the PI3K-Akt signalling pathway, suggesting a therapeutic benefit for hyperthyroidism and providing a basis for drug development targeting this condition.

References
1.
Bello L, Pegoraro E . The "Usual Suspects": Genes for Inflammation, Fibrosis, Regeneration, and Muscle Strength Modify Duchenne Muscular Dystrophy. J Clin Med. 2019; 8(5). PMC: 6571893. DOI: 10.3390/jcm8050649. View

2.
Sun J, Wei J, Zhang Y, Li J, Li J, Yan J . Plasma Exosomes Transfer miR-885-3p Targeting the AKT/NFκB Signaling Pathway to Improve the Sensitivity of Intravenous Glucocorticoid Therapy Against Graves Ophthalmopathy. Front Immunol. 2022; 13:819680. PMC: 8900193. DOI: 10.3389/fimmu.2022.819680. View

3.
Cheng C, Fang W, Lin J . Associations of serum keratin 1 with thyroid function and immunity in Graves' disease. PLoS One. 2023; 18(11):e0289345. PMC: 10686460. DOI: 10.1371/journal.pone.0289345. View

4.
Lou H, Wu L, Wang H, Wei R, Cheng J . The Potential Role of Osteopontin in the Pathogenesis of Graves' Ophthalmopathy. Invest Ophthalmol Vis Sci. 2021; 62(12):18. PMC: 8458783. DOI: 10.1167/iovs.62.12.18. View

5.
Feng Z, Song Y, Qian J, Chen T, Yang C, Jia L . Differential expression of a set of microRNA genes reveals the potential mechanism of papillary thyroid carcinoma. Ann Endocrinol (Paris). 2019; 80(2):77-83. DOI: 10.1016/j.ando.2018.07.014. View